Journal
BMJ Open
Publication Date
2-4-2022
Volume
12
Issue
2
First Page
e046953
Document Type
Open Access Publication
DOI
10.1136/bmjopen-2020-046953
Rights and Permissions
Ibrahim SA, Kang BY, Schlessinger DI, Chiren SG, Tang JC, Kirkham JJ, Schmitt J, Poon E, Maher IA, Sobanko JF, Cartee TV, Alam M. Protocol for development of a core outcome set for clinical trials in melasma. BMJ Open. 2022 Feb 4;12(2):e046953. doi: 10.1136/bmjopen-2020-046953. https://bmjopen.bmj.com/content/12/2/e046953 © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Ibrahim, Sarah; Kang, Bianca; Schlessinger, Daniel; Chiren, Sarah; Tang, Jennifer; Kirkham, Jamie; Schmitt, Jochen; Poon, Emily; Maher, Ian; Sobanko, Joseph; Cartee, Todd; and Alam, Murad, "Protocol for development of a core outcome set for clinical trials in melasma." BMJ Open. 12, 2. e046953 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11254
